Medical Developments International Limited’s (ASX:MVP) Share Price Boosted 27% But Its Business Prospects Need A Lift Too
The Medical Developments International Limited (ASX:MVP) share price has done very well over the last month, posting an excellent gain of 27%. The last 30 days bring the annual gain to a very sharp 71%.
Although its price has surged higher, Medical Developments International may still be sending very bullish signals at the moment with its price-to-sales (or “P/S”) ratio of 2.2x, since almost half of all companies in the Pharmaceuticals industry in Australia have P/S ratios greater than 13.8x and even P/S higher than 38x are not unusual. However, the P/S might be quite low for a reason and it requires further investigation to determine if it’s justified.
AI is about to change healthcare. These 20 stocks are working on…
